Literature DB >> 10065679

Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.

R Zalacain1, V Sobradillo, J Amilibia, J Barrón, V Achótegui, J I Pijoan, J L Llorente.   

Abstract

The aim of this prospective observational study was to determine those factors influencing bacterial colonization in patients with stable chronic obstructive pulmonary disease (COPD). Eighty-eight outpatients with stable COPD and 20 patients with normal spirometry and chest radiography (controls) had a fibreoptic bronchoscopy performed with topical aerosol anaesthesia. Bacterial colonization was determined using the protected specimen brush (PSB) with a cut-off > or = 10(3) colony-forming units (CFU x mL(-1)). The influence of age, degree of airflow obstruction, smoking habit, pack-yrs of smoking, and chest radiographic findings on bacterial colonization were assessed by univariate and multivariate analysis. Significant bacterial growth was found in 40% of patients and in none of the controls. Haemophilus influenzae, Streptococcus viridans, S. pneumoniae and Moraxella catarrhalis were the most frequent pathogens. After adjustment for other variables, severe airflow limitation (odds ratio (OR) 5.11, 95% confidence interval (CI) 1.45-17.9) and current smoking (OR 3.17, 95% CI 2.5-8) remained associated with positive bacterial cultures. When only potentially pathogenic micro-organisms were considered, significant bacterial growth was found in 30.7% of patients, with severe airflow obstruction (OR 9.28, 95% CI 2.19-39.3) being the only variable independently associated with positive bacterial cultures. Our results show that stable chronic obstructive pulmonary disease patients have a high prevalence of bacterial colonization of distal airways which is mainly related to the degree of airflow obstruction and cigarette smoking.

Entities:  

Mesh:

Year:  1999        PMID: 10065679     DOI: 10.1034/j.1399-3003.1999.13b21.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  60 in total

Review 1.  Home treatment of COPD exacerbations.

Authors:  D S Postma; N H Ten Hacken; H A Kerstjens; G H Koëter
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease.

Authors:  J A Wedzicha
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

Review 3.  The role of the microbiome in exacerbations of chronic lung diseases.

Authors:  Robert P Dickson; Fernando J Martinez; Gary B Huffnagle
Journal:  Lancet       Date:  2014-08-23       Impact factor: 79.321

Review 4.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

5.  Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Jane Maloney; Lori Grove; Catherine Wrona; Charles S Berenson
Journal:  Am J Respir Crit Care Med       Date:  2006-02-10       Impact factor: 21.405

6.  Spatial Variation in the Healthy Human Lung Microbiome and the Adapted Island Model of Lung Biogeography.

Authors:  Robert P Dickson; John R Erb-Downward; Christine M Freeman; Lisa McCloskey; James M Beck; Gary B Huffnagle; Jeffrey L Curtis
Journal:  Ann Am Thorac Soc       Date:  2015-06

7.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.

Authors:  I S Patel; T A R Seemungal; M Wilks; S J Lloyd-Owen; G C Donaldson; J A Wedzicha
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

8.  Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease.

Authors:  Marc Miravitlles; Alicia Marín; Eduard Monsó; Sara Vilà; Cristian de la Roza; Ramona Hervás; Cristina Esquinas; Marian García; Laura Millares; Josep Morera; Antoni Torres
Journal:  Respir Res       Date:  2010-05-14

9.  Proteomic expression profiling of Haemophilus influenzae grown in pooled human sputum from adults with chronic obstructive pulmonary disease reveal antioxidant and stress responses.

Authors:  Jun Qu; Alan J Lesse; Aimee L Brauer; Jin Cao; Steven R Gill; Timothy F Murphy
Journal:  BMC Microbiol       Date:  2010-06-01       Impact factor: 3.605

Review 10.  Newer fluoroquinolones in the treatment of acute exacerbations of COPD.

Authors:  Amit Patel; Robert Wilson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.